Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany, Austria and Switzerland - BALANCE
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms BALANCE
- Sponsors AbbVie
- 09 Aug 2016 Planned number of patients changed from 266 to 250.
- 13 Oct 2015 Planned number of patients changed from 250 to 266 as reported by ClinicalTrials.gov record.
- 29 Apr 2015 Planned number of patients changed from 266 to 250 as per ClinicalTrials.gov record.